Applied Genetic Technologies (AGTC) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free AGTC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 28, 2024 | finance.yahoo.comGenetic Technologies Limited (GENE)April 22, 2024 | finance.yahoo.comDry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034 | DelveInsightFebruary 8, 2024 | finance.yahoo.comBeacon Therapeutics Announces Positive 12-Month Data from Phase 2 SKYLINE Trial of AGTC-501 in Patients with X-Linked Retinitis PigmentosaJanuary 5, 2024 | marketwatch.comMetagenomi Technologies Files for Initial Public OfferingDecember 18, 2023 | msn.comA new mathematical language for biological networksOctober 23, 2023 | investing.comGenetic Technologies (GENE) Earnings Dates & ReportsJune 12, 2023 | lse.co.ukSyncona launches new gene therapy company with GBP96 million fundingJune 1, 2023 | msn.comNew AI tool searches genetic haystacks to find disease-causing variantsMay 17, 2023 | uk.finance.yahoo.comSania Therapeutics launches to advance novel medicines for neural circuit dysfunctionMay 1, 2023 | usnews.comApplied Technology CenterApril 27, 2023 | finance.yahoo.comAAV Vectors in Gene Therapy Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 70+ Companies Working in the DomainApril 21, 2023 | msn.comWorld-first technology from biomodal enables reading of genetic and epigenetic information using existing sequencersApril 1, 2023 | nbcnews.comElephant in the dining room: Startup creates mammoth meatballMarch 22, 2023 | bbc.co.ukGenetic control of metabolismMarch 16, 2023 | bbc.co.ukGenetic testing and cystic fibrosisJanuary 31, 2023 | yahoo.comRallybio Announces Appointment of Jonathan I. Lieber as Chief Financial OfficerJanuary 5, 2023 | thestreet.comApplied Genetic Technologies (AGTC) Stock Climbs on $124 Million Biogen DealDecember 1, 2022 | marketbeat.comTrading was temporarily halted for "AGTC" at 07:11 PM with a stated reason of "News pending."November 28, 2022 | finance.yahoo.com*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*November 22, 2022 | finance.yahoo.com*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *REMINDER*November 15, 2022 | finance.yahoo.comApplied Genetic Technologies Corporation Urges Shareholders to Tender Their Shares by November 28, 2022November 3, 2022 | finance.yahoo.comApplied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022October 25, 2022 | finance.yahoo.comFlorida investment firm looks to take Cambridge gene therapy startup privateOctober 24, 2022 | lse.co.ukSyncona to acquire retinal therapy firm Applied Genetic TechnologiesOctober 23, 2022 | finance.yahoo.comSyncona to Acquire Applied Genetic Technologies CorporationOctober 18, 2022 | markets.businessinsider.comiNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesisSeptember 30, 2022 | msn.comHC Wainwright & Co. Maintains Buy Rating for Applied Genetic: Here's What You Need To KnowSeptember 23, 2022 | fool.comApplied Genetic Technologies (NASDAQ: AGTC)August 29, 2022 | reuters.comApplied Genetic Technologies CorpJuly 26, 2022 | finance.yahoo.comAGTC Receives Positive Type C Meeting Feedback from the FDA for the Company’s Design and Operating Procedures of its Planned cGMP Manufacturing FacilityJuly 13, 2022 | finance.yahoo.comAGTC Announces Pricing of $10 Million Underwritten Public OfferingJuly 12, 2022 | finance.yahoo.comAGTC Announces Proposed Underwritten Public OfferingJune 8, 2022 | finance.yahoo.comAGTC Announces Key Appointments to Leadership TeamJune 6, 2022 | finance.yahoo.comAGTC to Present Three-Month Interim Results from the SKYLINE Clinical Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa at the 45th Macula Society Annual MeetingMay 18, 2022 | finance.yahoo.comAGTC to Present at the H.C. Wainwright Global Investment ConferenceMay 16, 2022 | finance.yahoo.comAGTC Announces Positive Three-Month Interim Results from Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis PigmentosaMay 10, 2022 | finance.yahoo.comAGTC Hosts Topping Off Ceremony for Gene Therapy Manufacturing Facility to Celebrate the Building’s Structural CompletionMay 4, 2022 | finance.yahoo.comPositive 18-Month Data from Ongoing Phase 1/2 Clinical Study of AGTC-501 Presented at the Association for Research in Vision and Ophthalmology 2022 Annual MeetingMay 2, 2022 | tmcnet.comAGTC to Present Preclinical Research Supporting Gene TherapyMay 2, 2022 | finance.yahoo.comAGTC to Present Preclinical Research Supporting Gene Therapy Platform in Frontotemporal Dementia at the 25th Annual Meeting of the American Society of Gene & Cell TherapyApril 14, 2022 | finance.yahoo.comAGTC to Present at Cell & Gene Meeting on the MediterraneanMarch 22, 2022 | finance.yahoo.comAGTC Announces Pricing of Public Offering of Common StockMarch 8, 2022 | finance.yahoo.comAGTC to Participate in Upcoming Investor ConferencesFebruary 7, 2022 | finance.yahoo.comAGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 14, 2022January 11, 2022 | finance.yahoo.comAGTC Exceeds Enrollment Target in SKYLINE Trial of AGTC-501 for the Treatment of X-linked Retinitis Pigmentosa (XLRP)January 4, 2022 | finance.yahoo.comAGTC to Participate in the H.C. Wainwright BioConnect 2022 ConferenceDecember 29, 2021 | nasdaq.comApplied Genetic Technologies Corp Shares Approach 52-Week Low - Market MoverDecember 29, 2021 | nasdaq.comApplied Genetic Technologies Corp Shares Approach 52-Week Low - Market MoverDecember 10, 2021 | marketbeat.comApplied Genetic Technologies (NASDAQ:AGTC) Upgraded at Zacks Investment ResearchZacks Investment Research raised Applied Genetic Technologies from a "sell" rating to a "hold" rating in a research note on Friday.December 6, 2021 | finance.yahoo.comAGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors Get Applied Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter. Email Address This military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. AGTC Media Mentions By Week AGTC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGTC News Sentiment▼0.340.76▲Average Medical News Sentiment AGTC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGTC Articles This Week▼00▲AGTC Articles Average Week Get Applied Genetic Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AGTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: bluebird bio News Athira Pharma News Cognition Therapeutics News Precision BioSciences News AlloVir News Gritstone bio News Protalix BioTherapeutics News BioAtla News Elutia News Atara Biotherapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AGTC) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Genetic Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
